<?xml version="1.0" encoding="UTF-8"?>
<ref id="B73-ijms-21-01376">
 <label>73.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Marty</surname>
    <given-names>F.M.</given-names>
   </name>
   <name>
    <surname>Winston</surname>
    <given-names>D.J.</given-names>
   </name>
   <name>
    <surname>Chemaly</surname>
    <given-names>R.F.</given-names>
   </name>
   <name>
    <surname>Mullane</surname>
    <given-names>K.M.</given-names>
   </name>
   <name>
    <surname>Shore</surname>
    <given-names>T.B.</given-names>
   </name>
   <name>
    <surname>Papanicolaou</surname>
    <given-names>G.A.</given-names>
   </name>
   <name>
    <surname>Chittick</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Brundage</surname>
    <given-names>T.M.</given-names>
   </name>
   <name>
    <surname>Wilson</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Morrison</surname>
    <given-names>M.E.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A randomized, double-blind, placebo-controlled phase 3 trial of oral brincidofovir for cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplantation</article-title>
  <source>Biol. Blood Marrow Transpl.</source>
  <year>2019</year>
  <volume>25</volume>
  <fpage>369</fpage>
  <lpage>381</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bbmt.2018.09.038</pub-id>
  <?supplied-pmid 30292744?>
  <pub-id pub-id-type="pmid">30292744</pub-id>
 </element-citation>
</ref>
